Cargando…
Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
This study is to identify significant dosimetric parameters for ear disorders in nasopharyngeal carcinoma (NPC) patients treated with intensity modulated therapy only. Ninety-seven patients with NPC were retrospectively reviewed. Organs at risk (OARs) in the auditory apparatus were contoured. Dose–v...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642560/ https://www.ncbi.nlm.nih.gov/pubmed/26323586 http://dx.doi.org/10.1038/srep13525 |
_version_ | 1782400379533656064 |
---|---|
author | Yao, Ji-Jin Zhou, Guan-Qun Lin, Li Zhang, Wang-Jian Peng, Ying-Lin Chen, Lei Tang, Ling-Long Mao, Yan-Ping Ma, Jun Sun, Ying |
author_facet | Yao, Ji-Jin Zhou, Guan-Qun Lin, Li Zhang, Wang-Jian Peng, Ying-Lin Chen, Lei Tang, Ling-Long Mao, Yan-Ping Ma, Jun Sun, Ying |
author_sort | Yao, Ji-Jin |
collection | PubMed |
description | This study is to identify significant dosimetric parameters for ear disorders in nasopharyngeal carcinoma (NPC) patients treated with intensity modulated therapy only. Ninety-seven patients with NPC were retrospectively reviewed. Organs at risk (OARs) in the auditory apparatus were contoured. Dose–volume histogram parameters were generated for the Eustachian tube (ET), tympanic cavity (TC), mastoid air cells, vestibular apparatus, cochlea and internal auditory canal (IAC). Ear disorders were rated 0 (none), 1 (mild) or 2 (severe) by a clinician blinded to radiation doses; Grade 2 ear disorders was the study end-point. Multivariate analysis revealed ET.D(30) (dose to 30% of ET volume) >52.75 Gy and M.D(0.5CC) (dose to 0.5 ml of mastoid volume) >41.04 Gy (OR = 3.77, P = 0.012 and OR = 1.27, P = 0.033, respectively) were associated with Grade 2 ear disorders. Our results demonstrated that post-irradiation ear disorders remain a common late toxicity in NPC after IMRT. ET.D(30) and M.D(0.5CC) should be considered during IMRT treatment plan optimization, review and approval. |
format | Online Article Text |
id | pubmed-4642560 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-46425602015-11-20 Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma Yao, Ji-Jin Zhou, Guan-Qun Lin, Li Zhang, Wang-Jian Peng, Ying-Lin Chen, Lei Tang, Ling-Long Mao, Yan-Ping Ma, Jun Sun, Ying Sci Rep Article This study is to identify significant dosimetric parameters for ear disorders in nasopharyngeal carcinoma (NPC) patients treated with intensity modulated therapy only. Ninety-seven patients with NPC were retrospectively reviewed. Organs at risk (OARs) in the auditory apparatus were contoured. Dose–volume histogram parameters were generated for the Eustachian tube (ET), tympanic cavity (TC), mastoid air cells, vestibular apparatus, cochlea and internal auditory canal (IAC). Ear disorders were rated 0 (none), 1 (mild) or 2 (severe) by a clinician blinded to radiation doses; Grade 2 ear disorders was the study end-point. Multivariate analysis revealed ET.D(30) (dose to 30% of ET volume) >52.75 Gy and M.D(0.5CC) (dose to 0.5 ml of mastoid volume) >41.04 Gy (OR = 3.77, P = 0.012 and OR = 1.27, P = 0.033, respectively) were associated with Grade 2 ear disorders. Our results demonstrated that post-irradiation ear disorders remain a common late toxicity in NPC after IMRT. ET.D(30) and M.D(0.5CC) should be considered during IMRT treatment plan optimization, review and approval. Nature Publishing Group 2015-09-01 /pmc/articles/PMC4642560/ /pubmed/26323586 http://dx.doi.org/10.1038/srep13525 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Yao, Ji-Jin Zhou, Guan-Qun Lin, Li Zhang, Wang-Jian Peng, Ying-Lin Chen, Lei Tang, Ling-Long Mao, Yan-Ping Ma, Jun Sun, Ying Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma |
title | Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma |
title_full | Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma |
title_fullStr | Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma |
title_full_unstemmed | Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma |
title_short | Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma |
title_sort | dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642560/ https://www.ncbi.nlm.nih.gov/pubmed/26323586 http://dx.doi.org/10.1038/srep13525 |
work_keys_str_mv | AT yaojijin dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma AT zhouguanqun dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma AT linli dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma AT zhangwangjian dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma AT pengyinglin dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma AT chenlei dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma AT tanglinglong dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma AT maoyanping dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma AT majun dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma AT sunying dosevolumefactorsassociatedwitheardisordersfollowingintensitymodulatedradiotherapyinnasopharyngealcarcinoma |